SCHEMBL8964001

SCHEMBL8964001

COc1ccc(-c2nc(C(=O)CBr)c(C)[nH]2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIN1 Q13526 2/20 0.51
▸ GSK3B P49841 1/20 0.49
▸ PARP1 P09874 3/20 0.43
▸ PLA2G2A P14555 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ NOX1 Q9Y5S8 1/20 0.43
▸ MAPT P10636 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963666 0.85 PIN1 (0.73) PIN1PARP1KDM4EALDH1A1CYP1A2
SCHEMBL8963571 0.83 PIN1 (0.50) PIN1GSK3BPARP1MAPTKDM4E
SCHEMBL8964177 0.83 PIN1 (0.56) PIN1PARP1PLA2G2AALOX15PTGS2
SCHEMBL8963968 0.83 PIN1 (0.69) PIN1GSK3BMAPTKDM4ECYP1A2
SCHEMBL28297325 0.81 KDM4E (0.60) PIN1MAPTKDM4EALDH1A1NPC1
SCHEMBL8963842 0.81 PIN1 (0.48) PIN1PARP1MAPTKDM4EALDH1A1
SCHEMBL8963967 0.76 SLC9A1 (0.58) PIN1PARP1ALOX15SLC9A1
SCHEMBL8963720 0.76 PIN1 (0.71) PIN1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10679043 0.75 PIN1 (0.50) PIN1MAPTKDM4EALDH1A1HPGD
Oxalic Acid SCHEMBL31679103 0.74 SMPD3 (0.50) PIN1PARP1PLA2G2AALOX15PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 — — US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 — — US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 — — US disclosed
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 — — EP disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 — — US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 — — US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 — — US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 — — US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 — — US disclosed
EP-0289227-A1 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS LTD. (GB) 1988-11-02 — — EP disclosed
Send feedback